TORONTO, Aug. 4, 2023 /CNW/ - Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow, and reverse chronic disease, announced today that it will release its financial results for the quarter ended June 30, 2023, after market close on Wednesday, August 9, 2023. The Company will also host a conference call that day at 5:00 p.m. Eastern Time to discuss the second quarter 2023 results in further detail.
To access the conference call, please dial (888) 886-7786 (U.S.) or (416) 764-8658 (International) ten minutes prior to the start time. The call will also be available via live webcast on the investor relations portion of the Company's website located at newtopia.com/investors.
If you cannot listen to the conference call at its scheduled time, there will be a replay available through Wednesday, August 30, 2023, which can be accessed by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International) and entering the passcode 03837842. The webcast will also be archived on the Company's website.
Newtopia is a tech-enabled whole health platform helping people create positive lifelong habits that prevent, slow, or reverse chronic disease while reducing healthcare costs. The platform leverages genetic, social and behavioural insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed in Canada on the Toronto Stock Exchange (TSXV: NEWU) and is quoted in the US on the OTCQB® Venture Market (OTCQB: NEWUF). To learn more, visit newtopia.com, LinkedIn or Twitter.
SOURCE Newtopia Inc.
Chief Executive Officer: Jeff Ruby, [email protected], 888-639-8181; Investor Relations: [email protected]
Share this article